<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01746121</url>
  </required_header>
  <id_info>
    <org_study_id>4266</org_study_id>
    <nct_id>NCT01746121</nct_id>
  </id_info>
  <brief_title>Amelogenesis Imperfecta</brief_title>
  <official_title>Clinical and Molecular Study of Amelogenesis Imperfecta</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Amelogenesis Imperfecta (AI) are a heterogeneous group of rare genetic diseases transmitted&#xD;
      according to various mode of inheritance (X-linked, autosomal dominant, autosomal recessive)&#xD;
      affecting the formation/mineralization of tooth enamel. These diseases exist in isolation&#xD;
      with clinical manifestations limited to the oral cavity or may be associated to other&#xD;
      symptoms in syndromes. Many different genes (AMELX, ENAM, ENAMELYSIN or MMP20, KLK4, DLX3,&#xD;
      FAM83H, FAM20A WDR72…) coding for enamel matrix proteins, enamel matrix degrading proteins,&#xD;
      proteins involved in hydroxyapatite formation and growth and mineralization processes have&#xD;
      been discovered responsible for the clinical phenotypes (hypoplastic, hypomineralized,&#xD;
      hypomature) encountered in AI.&#xD;
&#xD;
      Genes involved in enamel formation but not yet identified in association with any form of AI&#xD;
      include: AMELY, AMELOBLASTIN, TUFTELIN, AMELOTIN, A Pin protein, ODAM (Odontogenic ameloblast&#xD;
      associated).&#xD;
&#xD;
      In this research protocol the investigators explore the phenotype including the enamel&#xD;
      ultrastructure and the genotype of a cohort of patients presenting AI.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <start_date type="Actual">November 2009</start_date>
  <completion_date type="Actual">January 2016</completion_date>
  <primary_completion_date type="Actual">March 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Family-Based</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Natural history of Amelogenesis Imperfecta</measure>
    <time_frame>at day of enrollment</time_frame>
    <description>Familial, medical, dental history</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Phenotype of Amelogenesis Imperfecta</measure>
    <time_frame>at day of enrollment</time_frame>
    <description>Clinical and radiographic examination Type of enamel defects Associated dental or craniofacial anomalies</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Genetic Bases of Amelogenesis Imperfecta</measure>
    <time_frame>within 3 years after enrollment</time_frame>
    <description>Genetic analysis</description>
  </other_outcome>
  <other_outcome>
    <measure>Ultrastructure of teeth hard tissues</measure>
    <time_frame>within 3 years after enrollment</time_frame>
    <description>Ultrastructure analysis of teeth hard tissues</description>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">600</enrollment>
  <condition>Amelogenesis Imperfecta</condition>
  <arm_group>
    <arm_group_label>Amelogenesis Imperfecta</arm_group_label>
    <description>Salivary and blood sampling, as part of routine care. Collection of exfoliated teeth</description>
  </arm_group>
  <arm_group>
    <arm_group_label>healthy family members</arm_group_label>
    <description>Salivary and blood sampling, as part of routine care. Collection of exfoliated teeth</description>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Salivary and blood sampling, as part of routine care. Collection of exfoliated teeth.</intervention_name>
    <arm_group_label>Amelogenesis Imperfecta</arm_group_label>
    <arm_group_label>healthy family members</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      saliva&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The recruitment of patients comes from several sources. A first cohort of 40 families is&#xD;
        already followed by the reference center of Strasbourg. The reference center for rare&#xD;
        diseases dental manifestations of Strasbourg recruiting patients at regional,&#xD;
        interregional, national and international scale.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  Patient presenting with AI&#xD;
&#xD;
          -  New patient or patient already known in the center&#xD;
&#xD;
          -  Child (in his primary dentition) or adult&#xD;
&#xD;
          -  Man or woman&#xD;
&#xD;
          -  Having signed a consent form or accepted to participate to the study&#xD;
&#xD;
          -  Patient affiliated to social security&#xD;
&#xD;
          -  Validation of the inclusion by the principal investigator looking at the patient file&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Patient with acquired enamel defects&#xD;
&#xD;
          -  Patient whose clinical diagnostic is not possible&#xD;
&#xD;
          -  Patient whose clinical file does not contain teeth photos&#xD;
&#xD;
          -  Patient who has not signed a consent form and accepted to participate to the study&#xD;
&#xD;
          -  Patient who is not affiliated to social security.&#xD;
&#xD;
          -  Non validation of the inclusion by the principal investigator looking at the patient&#xD;
             file&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bloch-Zupan Agnes, DChD, PhD, HDR, PU-PH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital of Strasbourg</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hôpitaux Universitaires de Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <state>Alsace</state>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <study_first_submitted>October 22, 2012</study_first_submitted>
  <study_first_submitted_qc>December 6, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 10, 2012</study_first_posted>
  <last_update_submitted>July 10, 2018</last_update_submitted>
  <last_update_submitted_qc>July 10, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amelogenesis Imperfecta</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

